CN105343541A - 一种具有清热解毒功效的肛乳头中药制剂 - Google Patents
一种具有清热解毒功效的肛乳头中药制剂 Download PDFInfo
- Publication number
- CN105343541A CN105343541A CN201510855758.8A CN201510855758A CN105343541A CN 105343541 A CN105343541 A CN 105343541A CN 201510855758 A CN201510855758 A CN 201510855758A CN 105343541 A CN105343541 A CN 105343541A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- anal
- heat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 66
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 230000006870 function Effects 0.000 title claims abstract description 21
- 241000628997 Flos Species 0.000 claims description 18
- 239000009286 sanguis draxonis Substances 0.000 claims description 18
- 239000003610 charcoal Substances 0.000 claims description 17
- 229940079593 drug Drugs 0.000 claims description 16
- 239000007921 spray Substances 0.000 claims description 7
- 239000000829 suppository Substances 0.000 claims description 6
- 241000792859 Enema Species 0.000 claims description 5
- 239000007920 enema Substances 0.000 claims description 5
- 229940095399 enema Drugs 0.000 claims description 5
- 239000002674 ointment Substances 0.000 claims description 5
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000006210 lotion Substances 0.000 claims description 4
- -1 tincture Substances 0.000 claims description 2
- 229940098465 tincture Drugs 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 57
- 210000004369 blood Anatomy 0.000 abstract description 53
- 208000002193 Pain Diseases 0.000 abstract description 43
- 230000000694 effects Effects 0.000 abstract description 22
- 230000001737 promoting effect Effects 0.000 abstract description 20
- 230000008961 swelling Effects 0.000 abstract description 15
- 230000017531 blood circulation Effects 0.000 abstract description 14
- 230000009471 action Effects 0.000 abstract description 6
- 235000013399 edible fruits Nutrition 0.000 abstract description 6
- 230000017423 tissue regeneration Effects 0.000 abstract description 6
- 239000003053 toxin Substances 0.000 abstract description 6
- 238000002347 injection Methods 0.000 abstract description 4
- 239000007924 injection Substances 0.000 abstract description 4
- 231100000765 toxin Toxicity 0.000 abstract description 2
- 230000003247 decreasing effect Effects 0.000 abstract 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241001071917 Lithospermum Species 0.000 abstract 1
- 240000009215 Nepeta cataria Species 0.000 abstract 1
- 235000010679 Nepeta cataria Nutrition 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 244000148137 Patrinia villosa Species 0.000 abstract 1
- 235000019109 Patrinia villosa Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 244000173853 Sanguisorba officinalis Species 0.000 abstract 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 241000246044 Sophora flavescens Species 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 230000001914 calming effect Effects 0.000 abstract 1
- 238000007599 discharging Methods 0.000 abstract 1
- ZDKZHVNKFOXMND-UHFFFAOYSA-N epinepetalactone Chemical compound O=C1OC=C(C)C2C1C(C)CC2 ZDKZHVNKFOXMND-UHFFFAOYSA-N 0.000 abstract 1
- 230000002045 lasting effect Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 23
- 238000010438 heat treatment Methods 0.000 description 22
- 239000007788 liquid Substances 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 210000000436 anus Anatomy 0.000 description 16
- 238000000108 ultra-filtration Methods 0.000 description 16
- 206010007247 Carbuncle Diseases 0.000 description 12
- 238000000605 extraction Methods 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 238000004821 distillation Methods 0.000 description 11
- 208000001848 dysentery Diseases 0.000 description 11
- 208000032843 Hemorrhage Diseases 0.000 description 10
- 210000001015 abdomen Anatomy 0.000 description 10
- 230000013872 defecation Effects 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 210000002445 nipple Anatomy 0.000 description 10
- 230000001717 pathogenic effect Effects 0.000 description 10
- 239000006228 supernatant Substances 0.000 description 10
- 201000010183 Papilledema Diseases 0.000 description 9
- 206010033708 Papillitis Diseases 0.000 description 9
- 201000002166 optic papillitis Diseases 0.000 description 9
- 231100000614 poison Toxicity 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 230000002829 reductive effect Effects 0.000 description 9
- 208000006820 Arthralgia Diseases 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 8
- 208000003251 Pruritus Diseases 0.000 description 8
- 210000003503 anal sac Anatomy 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 208000035861 hematochezia Diseases 0.000 description 8
- 230000023597 hemostasis Effects 0.000 description 8
- 230000004054 inflammatory process Effects 0.000 description 8
- 238000010992 reflux Methods 0.000 description 8
- 201000000736 Amenorrhea Diseases 0.000 description 7
- 206010001928 Amenorrhoea Diseases 0.000 description 7
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 7
- 231100000540 amenorrhea Toxicity 0.000 description 7
- 230000003110 anti-inflammatory effect Effects 0.000 description 7
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 7
- 229960003321 baicalin Drugs 0.000 description 7
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 7
- 238000002425 crystallisation Methods 0.000 description 7
- 230000008025 crystallization Effects 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 208000037920 primary disease Diseases 0.000 description 7
- 230000000638 stimulation Effects 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 239000003440 toxic substance Substances 0.000 description 7
- 206010013935 Dysmenorrhoea Diseases 0.000 description 6
- 206010027514 Metrorrhagia Diseases 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 210000000981 epithelium Anatomy 0.000 description 6
- 208000014617 hemorrhoid Diseases 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 239000002398 materia medica Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 208000005171 Dysmenorrhea Diseases 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- 208000019255 Menstrual disease Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 208000025865 Ulcer Diseases 0.000 description 5
- 239000000571 coke Substances 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 208000001780 epistaxis Diseases 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 238000005469 granulation Methods 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 210000002429 large intestine Anatomy 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 210000003932 urinary bladder Anatomy 0.000 description 5
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 4
- 206010020880 Hypertrophy Diseases 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 208000037062 Polyps Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 206010038074 Rectal polyp Diseases 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 4
- 206010040943 Skin Ulcer Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000002481 ethanol extraction Methods 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 230000002757 inflammatory effect Effects 0.000 description 4
- 230000009545 invasion Effects 0.000 description 4
- 230000002147 killing effect Effects 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 208000022075 polyp of rectum Diseases 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000001047 pyretic effect Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 230000000552 rheumatic effect Effects 0.000 description 4
- 238000004062 sedimentation Methods 0.000 description 4
- 210000000582 semen Anatomy 0.000 description 4
- 231100000019 skin ulcer Toxicity 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 241000700199 Cavia porcellus Species 0.000 description 3
- 206010063560 Excessive granulation tissue Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 208000007101 Muscle Cramp Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 210000002255 anal canal Anatomy 0.000 description 3
- 230000001754 anti-pyretic effect Effects 0.000 description 3
- 239000002221 antipyretic Substances 0.000 description 3
- 208000034158 bleeding Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 210000001126 granulation tissue Anatomy 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000008338 local blood flow Effects 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 230000001926 lymphatic effect Effects 0.000 description 3
- 230000003211 malignant effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 230000004089 microcirculation Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- 210000000578 peripheral nerve Anatomy 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 230000002085 persistent effect Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000011505 plaster Substances 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 238000004064 recycling Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 210000002460 smooth muscle Anatomy 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 210000001113 umbilicus Anatomy 0.000 description 3
- 230000024883 vasodilation Effects 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 206010068172 Anal pruritus Diseases 0.000 description 2
- 208000019838 Blood disease Diseases 0.000 description 2
- 206010007882 Cellulitis Diseases 0.000 description 2
- 206010009346 Clonus Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010023644 Lacrimation increased Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 208000009544 Pruritus Ani Diseases 0.000 description 2
- 208000004680 Rectal Fistula Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 208000038016 acute inflammation Diseases 0.000 description 2
- 230000006022 acute inflammation Effects 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 206010002156 anal fistula Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 150000002333 glycines Chemical class 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000014951 hematologic disease Diseases 0.000 description 2
- 208000018706 hematopoietic system disease Diseases 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 230000002439 hemostatic effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 230000004317 lacrimation Effects 0.000 description 2
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000013521 mastic Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 229960000502 poloxamer Drugs 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 210000000664 rectum Anatomy 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- QMGVPVSNSZLJIA-FVWCLLPLSA-N strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000009834 vaporization Methods 0.000 description 2
- 230000008016 vaporization Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 1
- 206010048946 Anal abscess Diseases 0.000 description 1
- 206010002153 Anal fissure Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000019751 Anorectal disease Diseases 0.000 description 1
- 206010061640 Anorectal infection Diseases 0.000 description 1
- 208000016583 Anus disease Diseases 0.000 description 1
- 235000010894 Artemisia argyi Nutrition 0.000 description 1
- 241001055174 Asterinides folium Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000001378 Carbon Tetrachloride Poisoning Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000009531 Fissure in Ano Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 208000032420 Latent Infection Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 240000003146 Lobelia chinensis Species 0.000 description 1
- 235000007421 Mentha citrata Nutrition 0.000 description 1
- 244000007703 Mentha citrata Species 0.000 description 1
- 235000008660 Mentha x piperita subsp citrata Nutrition 0.000 description 1
- 241001448624 Miliaria Species 0.000 description 1
- 241000893976 Nannizzia gypsea Species 0.000 description 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 208000015815 Rectal disease Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 206010039705 Scleritis Diseases 0.000 description 1
- 241000238370 Sepia Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241001279009 Strychnos toxifera Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 206010049514 Traumatic fracture Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 241001480046 Trichophyton schoenleinii Species 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001716 anti-fugal effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 244000030166 artemisia Species 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000009989 contractile response Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 208000037771 disease arising from reactivation of latent virus Diseases 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 201000010582 ecthyma Diseases 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000002061 histotrophic effect Effects 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 229940105902 mint extract Drugs 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 210000004623 platelet-rich plasma Anatomy 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229960005453 strychnine Drugs 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种具有清热解毒功效的肛乳头中药制剂,所述中药外用制剂中各种原料药的重量份数为:地榆炭10~20份,黄芩10~20份,百花蛇舌草10~20份,川芎10~20份,金银花10~20份,丹参10~20份,炒槐角10~20份,紫草10~20份,荆芥炭10~20份,败酱草10~20份,黄柏10~20份,大黄10~20份,鸡血藤10~20份,艾叶10~20份,血竭10~20份,白芷10~20份,白及10~20份,苦参10~20份。本发明具有清热解毒、泻火宁络、消肿止痛、祛瘀生新的功效,通过肛内注药,使药集中在病灶部位透入发挥,作用持久,从而达到活血化瘀,疏通经络,消肿止痛。
Description
技术领域
本发明涉及含有来源于植物组份的保健品,特别涉及一种具有清热解毒功效的肛乳头中药制剂。
背景技术
肛乳头位于齿线部直肠柱下端的上皮突起,呈锥体状尖朝下,如绿豆大小,呈乳白色,2-6个。受慢性炎症刺激可增大如柱状或胡桃状顶大蒂细,随排便脱出肛外,临床易误诊为直肠息肉。肛乳头肥大应积极治疗,做好预防。肛乳头炎的表现不明显,常会被患者忽视,不及时去就医。肛乳头炎主要表现为平时感到肛门内有异物感,随着乳头增生肥大,排便时乳头可脱出肛门外。小的乳头便后可自行回到肛门内,大的需用手推回肛门内。如不及时复位,可引起肛门水肿、胀痛。肿大乳头被刺激或破溃后,可使肛腺分泌增加,引起肛门部潮湿发痒。
肛窦底部有能够分泌液体的肛门腺和肛门腺导管,平时能分泌出粘性液体,润滑大便和保护直肠肛门。由于肛窦像一个漏斗,开口向上张着,粪便和其他脏东西,就很容易积存在窦里,同时也容易被硬的粪便擦伤弄破。细菌侵入之后就会引起肛窦内感染,并沿着肛门腺导管和肛门腺蔓延,所以肛窦炎又是引起多种肛门直肠病的根源,如肛门直肠周围脓肿、肛瘘、肛裂、痔疮、肛乳头炎等,肛管上皮癌的发生,也与慢性肛窦炎症的刺激有关。
直肠肛管主要生理功能是排便。而直肠息肉泛指直肠粘膜表面向肠腔突出的隆起性病变,以病理上来看,性质不一,有良性肿瘤,有炎症变化,一般认为结直肠癌起自息肉,故息肉作为癌前症,及早切除息肉能降低癌的发生。
肛乳头炎的临床表现,一般情况下可感到肛门内有异物感,排便时肛乳头可脱出肛门外,大的乳头可用手推回肛门内,如不及时复位,可引起肛门水肿、肿痛,小的乳头可自行回到肛门内。肿大的乳头可引起刺激性的肛腺分泌,从而引起肛门瘙痒及湿润。局部检查:可摸到肿大的肛乳头,窥器下可以看到小的肛乳头如三角形突起,大的肛乳头如黄豆或葡萄状隆起,质硬,表面光滑,头大蒂小,可脱出肛门外。其表面覆以上皮,呈灰白或黄白色。
排便时创伤或肛窦炎症都可以引起肛乳头的急性炎症,由于引流不畅及炎症的长期刺激,使肛乳头肥大,且多次的排便动作可使肛乳头逐渐伸长而成为带蒂的肿物,形似直肠息肉。中医认为,本病主要是因湿热下注导致肛门局部气血瘀滞所致。西医对此采用手术或消炎治疗,但很容易引起过敏,反复;中医外部治疗,可直达患处,大大提高治愈率,减少复发,是可行的方法。本病易反复发生,治疗期间应注意心理咨询与指导,告知患者本病发生的原因和发展规律,解除思想顾虑,配合治疗同时避免饮用浓茶、咖啡或食用辛辣刺激之物。
发明内容
本发明所要解决的技术问题在于,现代西医认为肛乳头炎只是炎症,消炎即可,目前患者只能缓解症状,实在不行就手术治疗。而中医中药因为使用不便,气味难闻,对生活节奏快速的现代人并不接受。通过肛内注药,使药集中在病灶部位透入发挥,作用持久,更有利于药物的吸收和药效的发挥。本发明可以加快局部血液循环,改善毛细血管的通透性,缓解平滑肌痉挛,减轻疼痛,减少渗出,带走代谢物及致痛炎性物质,减轻对末梢神经的刺激。加快局部代谢,促使血管扩张,淋巴回流,改善微循环,增强局部组织营养,防止感染,消炎、消肿、止痛,加速组织再生,改善上皮和肉芽组织的生长环境。从而达到活血化瘀,疏通经络,消肿止痛。
为解决上述技术问题,本发明提供一种具有清热解毒功效的肛乳头中药制剂,所述肛乳头中药制剂为外用制剂,其所述中药外用制剂中各种原料药的重量份数可以为:地榆炭10~20份,黄芩10~20份,百花蛇舌草10~20份,川芎10~20份,金银花10~20份,丹参10~20份,炒槐角10~20份,紫草10~20份,荆芥炭10~20份,败酱草10~20份,黄柏10~20份,大黄10~20份,鸡血藤10~20份,艾叶10~20份,血竭10~20份,白芷10~20份,白及10~20份,苦参10~20份。
优选地,其所述中药外用制剂中各种原料药的重量份数还可以为:地榆炭10~15份,黄芩10~15份,百花蛇舌草10~15份,川芎10~15份,金银花10~15份,丹参10~15份,炒槐角10~15份,紫草10~15份,荆芥炭10~15份,败酱草10~20份,黄柏10~20份,大黄10~20份,鸡血藤10~20份,艾叶10~20份,血竭10~20份,白芷10~20份,白及10~20份,苦参10~20份。
优选地,其所述中药外用制剂中各种原料药的重量份数也可以为:地榆炭10~20份,黄芩10~20份,百花蛇舌草10~20份,川芎10~20份,金银花10~20份,丹参10~20份,炒槐角10~20份,紫草10~20份,荆芥炭10~20份,败酱草10~15份,黄柏10~15份,大黄10~15份,鸡血藤10~15份,艾叶10~15份,血竭10~15份,白芷10~15份,白及10~15份,苦参10~15份。
为解决上述技术问题,本发明还提供一种具有清热解毒功效的肛乳头中药制剂的制备方法,其所述外用制剂的剂型为栓剂的制备方法包括:
a.将艾叶、血竭、白芷和白及蒸馏汽化成结晶,粉碎备用;
b.其余原料晾晒好放入粉碎机打成粗颗粒,泡入乙醇中24小时以上,加热回流提取2次,成组分1;
c.再取上述乙醇提取后的药渣加水,加热回流提取2次,成组分2;
d.将上述结晶粉末,加入上述两种提取液中,基质调和罐装定型,紫外线杀毒。
所述步骤b中,可以将浸泡好的其余原料放入乙醇中加热回流提取2次,每次1~2小时,将2次提取液合并静置,去上清液,合并提取液,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.36的浸膏,加热浓缩至膏状,静置备用,成为组分1。
所述步骤c中,可以将上述乙醇提取过的药渣加10倍量水加热回流提取2次,每次1~2小时,将2次提取液合并静置,去上清液,合并提取液,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.36的浸膏,加热浓缩至膏状,静置备用,成为组分2。
所述步骤d中,可以将上述组分1与组分2合并,减压回收乙醇后置入双效真空浓缩器中,浓缩至90℃时相对密度为1.05的浸膏,浓缩至每1ml含1g生药量,加上步骤a得到的结晶粉末,加入上述浓缩浸膏中,基质调和罐装定型,紫外线杀毒。
所述栓剂所用的基质选自:半合成脂肪酸甘油酯、泊洛沙姆、聚乙二醇、羊毛脂中的一种或多种;所述基质在温度50℃~60℃条件下加热融化,加入所述制备方法制得的药物膏体,水浴搅拌均匀,混合成粘稠的液体,灌注在塑料定型管内。
为解决上述技术问题,本发明再提供一种具有清热解毒功效的肛乳头中药制剂的制备方法,所述外用药物剂型为灌肠剂,其制备步骤为:将血竭、艾叶、白及和白芷用蒸馏法蒸馏汽化成结晶,粉碎机粉碎后过120目细筛,细粉备用;将将剩余的原料药材加入5-10倍重量份的水煎煮2次,每次1~2小时,将2次提取液合并静置,去上清液,合并提取液,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.36的浸膏,加热浓缩至糊状状,加入蒸馏汽化的结晶粉末,紫外线照射后装袋。
灌肠剂使用方法:取其药液,自然沉淀后取上清液加温浓缩至200mL。患者取侧卧位,取药液50mL,加温至37℃左右用注射器抽取药液,缓缓注人肛内。保留2~4h,每晚1次,10d为1疗程。一般用药1~2个疗程。
所述具有清热解毒功效的肛乳头中药制剂,其所述外用药物剂型可以为:喷雾剂、软膏、酊剂、膏剂、贴剂、中药熏洗剂、洗剂、栓剂或灌肠剂。
本发明具有清热解毒、泻火宁络、消肿止痛、祛瘀生新的功效,方中黄柏、黄芩、大黄、血竭,经药理作用证实,有较好的抗菌作用。通过肛内注药,使药集中在病灶部位透入发挥,作用持久,更有利于药物的吸收和药效的发挥。本发明可以加快局部血液循环,改善毛细血管的通透性,缓解平滑肌痉挛,减轻疼痛,减少渗出,带走代谢物及致痛炎性物质,减轻对末梢神经的刺激。加快局部代谢,促使血管扩张,淋巴回流,改善微循环,增强局部组织营养,防止感染,消炎、消肿、止痛,加速组织再生,改善上皮和肉芽组织的生长环境。从而达到活血化瘀,疏通经络,消肿止痛。
本病易反复发生,治疗期间应注意心理咨询与指导,告知患者本病发生的原因和发展规律,解除思想顾虑,配合治疗同时避免饮用浓茶、咖啡或食用辛辣刺激之物。
具体实施方式
肛乳头炎是一种重要的潜在感染病灶,约85%的肛门直肠感染性病变与肛窦感染有关。本病属祖国医学“脏毒”范畴,因湿热、热毒之邪蕴聚肛门,气血失和,日久气血壅遏、络脉瘀阻所致。现代医学认为肛闷的解剖排列是肛乳头容易发炎的重要原因,这一细致结构呈杯状口朝上,容易积存粪渣或被误吞人的外物通过肛管时损伤;便秘时长期下挣,引起肛门和直肠下端被动充血,减弱了局部对病菌入侵的抵抗力,病菌从其底部深人肛腺而引起炎症。
排便时创伤或肛窦炎症都可以引起肛乳头的急性炎症,由于引流不畅及炎症的长期刺激,使肛乳头肥大,且多次的排便动作可使肛乳头逐渐伸长而成为带蒂的肿物,形似直肠息肉。中医认为,本病主要是因湿热下注导致肛门局部气血瘀滞所致。
肛乳头炎是一种较常见的肛管疾病,由于该病经常有炎性分泌物外溢,所以容易继发肛门湿疹和肛隐窝炎,甚至会导致肛门周围脓肿,给人们正常的生活带来不便。目前对肛乳头炎的治疗及预防,尚缺少很好的方法。
肛乳头炎的临床表现,一般情况下可感到肛门内有异物感,排便时肛乳头可脱出肛门外,大的乳头可用手推回肛门内,如不及时复位,可引起肛门水肿、肿痛,小的乳头可自行回到肛门内。肿大的乳头可引起刺激性的肛腺分泌,从而引起肛门瘙痒及湿润。局部检查:可摸到肿大的肛乳头,窥器下可以看到小的肛乳头如三角形突起,大的肛乳头如黄豆或葡萄状隆起,质硬,表面光滑,头大蒂小,可脱出肛门外。其表面覆以上皮,呈灰白或黄白色。
本病易反复发生,治疗期间应注意心理咨询与指导,告知患者本病发生的原因和发展规律,解除思想顾虑,配合治疗同时避免饮用浓茶、咖啡或食用辛辣刺激之物。
外用膏药具有较高的稠度,故而其具备有效成分含量高、析出速度缓慢、作用长期持久、局部疗效切实等一系列优点。本发明有效成分可透入皮肤产生活血止痛化淤、通经走络、祛湿排毒、祛风散寒等效果,从根本上全方位针对病机特点而发挥疗效,改善病变周围组织营养,起到修复病组织的作用,最终达到治愈目的。
中医认为,本病主要是因湿热下注导致肛门局部气血瘀滞所致。方中黄芩清热利湿,白花蛇舌草、金银花清热解毒,地榆炭、槐角、赤芍、金银花、川芎、当归清热凉血、活血止痛,土茯苓利水消肿、润肠通便。熏洗方中黄柏、大黄、艾叶、地榆炭清热燥湿解毒,活血止痛。本发明具有清热解毒、泻火宁络、消肿止痛、祛瘀生新的功效,方中黄柏、黄芩、大黄、血竭,经药理作用证实,有较好的抗菌作用。通过肛内注药,使药集中在病灶部位透入发挥,作用持久,更有利于药物的吸收和药效的发挥。本发明可以加快局部血液循环,改善毛细血管的通透性,缓解平滑肌痉挛,减轻疼痛,减少渗出,带走代谢物及致痛炎性物质,减轻对末梢神经的刺激。加快局部代谢,促使血管扩张,淋巴回流,改善微循环,增强局部组织营养,防止感染,消炎、消肿、止痛,加速组织再生,改善上皮和肉芽组织的生长环境。从而达到活血化瘀,疏通经络,消肿止痛。
地榆炭:地榆苦酸;寒;无毒。归肝;肺;肾;大肠经。功效凉血止血,清热解毒,消肿敛疮。主治在;吐血,咯血,衄血,尿血,便血,痔血,血痢,崩漏,赤白带下,疮痈肿痛,湿疹,阴痒,水火烫伤,蛇虫咬伤。《纲目》:地榆,除下焦热,治大小便血证。止血,取上截切片炒用,其梢则能行血,不可不知。杨士瀛云:诸疮痛者加地榆,痒者加黄芩。《本草求真》:地榆,诸书皆言因其苦寒,则能入于下焦血分除热,俾热悉从下解。又言性沉而涩,凡人症患吐衄崩中肠风血痢等症,得此则能涩血不解。按此不无两歧,讵知其热不除,则血不止,其热既清,则血自安,且其性主收敛,既能清降,又能收涩,则清不虑其过泄,涩亦不虑其或滞,实力解热止血药也。地榆炭:《医宗说约》:“炒黑止血。”现行,取地榆片置锅内,用武火加热,炒至表面呈焦黑色,内部棕褐色,喷淋清水少许,灭尽火星,取出凉透。地输炭长于止血,常用于便血、尿血、崩漏等出血证。
白花蛇舌草又叫蛇舌草、二叶、竹叶菜、蛇利草。味微苦,甘,寒。入胃、大肠、小肠经,苦寒清热解毒,甘寒清利湿热,对痈肿、咽痛、蛇伤等有较强的解毒消痈作用。一般用于治疗疮毒、咽喉肿痛、肠痈腹痛、毒蛇咬伤,也用于热淋涩痛、小便不利。是拔毒祛湿的良药。
黄芩黄芩有清热燥湿,凉血安胎,解毒功效。主治温热病、上呼吸道感染、肺热咳嗽、湿热黄胆、肺炎、痢疾、咳血、目赤、胎动不安、高血压、痈肿疖疮等症。黄芩的临床应用抗菌比黄连还好,而且不产生抗药性。我们借助广谱抗菌作用强的特点,用在真菌培养杂菌感染特厉害,用黄芩提取液效果很好。《本草经疏》:黄芩,其性清肃,所以除邪:味苦所以燥湿;阴寒所以胜热,故主诸热。诸热者,邪热与遍热也,黄疸、肠僻、泄痢,皆湿热胜之病也,析其本,则诸病自瘳矣。苦寒能除湿热,所以小肠利而水自逐,源清则流洁也。血闭者,实热在血分,即热人血室,令人经闭不通,湿热解,则荣气清而自行也。恶疮疽蚀者,血热则留结,而为痈肿渍烂也:火疡者,火气伤血也,凉血除热,则自愈也。黄芩有抗变态反应及抗炎作用:黄芩所含黄芩甙与黄芩素能明显抑制致敏豚鼠离体小肠与离体气管对抗原所产生的过敏性收缩反应,对豚鼠与小鼠的被动全身性变态反应以及豚鼠被动性皮肤变态反应,黄芩甙与黄芩素亦有抑制作用。黄芩有解热作用,多数试验证明,黄芩的有效成份黄芩甙元有解热作用。黄芩有解毒作用,黄芩甙有明显的解毒作用,这可能是由于在β-葡萄糖醛酸甙酶的作用下,黄芩甙分解出葡萄糖醛酸,并与多种毒物结合所致。黄芩甙10毫克能提高士的宁的LD50达2.5倍,并且使四氯化碳中毒小鼠的肝糖原含量增多。
金银花:《本草纲目》载“金银花,善于化毒,故治痈疽、肿毒、疮癣……”。自古以来,金银花常用于清热解毒,治疗温病发热,热毒血痢,痈疡等症。现代药理研究表明,金银花具有抑菌、抗病毒、抗炎、解热、调节免疫等作用中医认为,金银花性寒、味甘、气平,具有清热解毒之功效,可以治疗热毒肿疡、痈疽疔疮等症。且兼有宣散作用。金银花清热解毒作用颇强,在外科中为常用之品,一般用于有红肿热痛的疮痈肿毒。炒槐角:苦,寒。归肝、大肠经。功能与主治:清热泻火,凉血止血。用于肠热便血,痔肿出血,肝热头痛,眩晕目赤。槐角味苦,性寒。归肝、大肠经。有清热泻火、凉血止血功能。用于肠热便血,痔肿出血,肝热头痛,眩晕目赤。《本草求原》槐角润肝养血。治疳,疔,血痢,崩血;其角中核子,补脑,杀虫。
荆芥炭又名黑荆芥。是将荆芥切段后,用武火炒至焦黑色,存性,少喷清水,取出晾干入药者。主治:治便血,崩漏,产后血晕。取净荆芥段,照炒炭法炒至表面焦黑色,内部焦黄色,喷淋清水少许,熄灭火星,取出,晾干。血见黑则止,荆芥炒炭,色黑主人血分,性主收敛,故以止血见长。由于荆芥性本疏散,故其炭品止血无收敛太过之虑,是治疗妇产科出血、大便下血的常用药。为保证荆芥炭良好的止血疗效,优化荆芥炭的制备方法,把握客观的制炭标准是重要的。
丹参苦,微寒。归心、肝经。祛瘀止痛,活血通经,清心除烦。用于月经不调,经闭痛经,症瘕积聚,胸腹刺痛,热痹疼痛,疮疡肿痛,心烦不眠。用于胸肋胁痛,风湿痹痛,症瘕结块,疮疡肿痛,跌仆伤痛,月经不调,经闭痛经,产后瘀痛等。治疗胸肋疼痛、症瘕结块,以及月经不调、经闭经痛具有良效。《纲目》载:丹参,按《妇人明理论》云,四物汤治妇人病,不问产前产后,经水多少,皆可通用,惟一味丹参散,主治与之相同。盖丹参能破宿血,补新血,安生胎,落死胎,止崩中滞下,调经脉。丹参主要成分丹参酮有扩张血管、改善循环、解除血管内凝血等作用,具有活血化痕之功效,并能促进肝脏血液循环,利于肝细胞再生。
川芎辛,温。入肝、胆经。行气开郁,法风燥湿,活血止痛。治风冷头痛旋晕,胁痛腹疼,寒痹筋挛,经闭,难产,产后瘀阻块痛,痈疽疮疡。用于月经不调,经闭痛经,瘕腹痛,胸胁刺痛,跌扑肿痛,头痛,风湿痹痛。《本经》载其:主中风入脑头痛,寒痹,筋挛缓急,金创,妇人血闭无子。《别录》载其:″除脑中冷动,面上游风去来,目泪出,多涕唾,忽忽如醉,诸寒冷气,心腹坚痛,中恶,卒急肿痛,胁风痛,温中内寒。″是行气化瘀的良药。
鸡血藤性苦、甘,温。归肝、肾经,补血,活血,通络。用于月经不调,血虚萎黄,麻木瘫痪,风湿痹痛活血舒筋;养血调经,《本草纲目拾遗》载其能医手足麻木;肢体瘫痪;风湿痹痛;妇女有经不调;痛经。是活血良药。
黄柏主治清热燥湿,泻火除蒸,解毒疗疮。《中国药典》介绍黄柏清热燥湿之力,与黄芩、黄连相似,但以除下焦之湿热为佳,是治湿热疮疡的良药。
大黄又名将军(李当之《药录》),黄良,火参,肤如吴普。古人用其“主下淤血,血闭,寒热,破症瘕积聚,留饮宿食,荡涤肠胃,推陈致新,通利水谷,调中化食,安和五脏”。大黄用于治疗烧伤、烫伤在我国历史久远。《本草蒙鉴》记载:“大黄味苦,气大寒,阴中之阴,若研末鸡清调稠,可敷上火疮取效。”;《药鉴》记载:“大黄熟用则治诸火毒疮,久不收口。盖以诸毒火疮,皆属火毒,大黄熟用,则能泄火毒,且消肿止痛。”
血竭散瘀定痛,止血生肌。治跌打折损,内伤瘀痛;外伤出血不止,瘰疬,臁疮溃久不合。《唐本草》:主五脏邪气,带下,止痛,破积血,金创生肉。《海药本草》:主打伤折损,一切疼痛,补虚及血气搅刺,内伤血聚,并宜酒服。内服活血散瘀,定痛,外用止血生肌,敛疮。主治淤血经闭、痛经,产后瘀阻。症瘕痞块,胸腹刺痛。跌打损伤,淤血肿痛。外伤出血,溃疡不敛。抗真菌作用:血竭水浸剂(1∶2)在试营内对堇色毛癣菌、石膏样毛癣菌、许兰氏黄癣菌等多种致病真菌有不同程度的抑制作用。止血作用:动物实验证明,本品能显著缩短家兔血浆再钙化时间,从而增加其凝血作用。对血液流变性的影响:血竭水煎醇沉液(1∶1)0.5ml/kg肌内注射连续3周,使兔血红细胞压积减少,红细胞及血小板电泳时间缩短,但对全血粘度比值及血浆粘度比值无明显影响。对血小板聚集功能的影响:血竭水煎醇沉液(1∶1)0.1ml体外试验,加于0.5ml富血小板血浆内,对ADP诱导的血小板聚集有抑制作用
艾叶辛、苦,温;有小毒。归肝、脾、肾经。散寒止痛,温经止血。用于少腹冷痛,经寒不调,宫冷不孕,吐血,衄血,崩漏经多,妊娠下血;外治皮肤瘙痒,脱皮。醋艾炭温经止血。用于虚寒性出血。《唐本草》:主下血,衄血,脓血痢,水煮及丸散任用。
白及苦、甘、涩,微寒。归肺、肝、胃经。补肺,止血,消肿,生肌,敛疮。治肺伤咳血,衄血,金疮出血,痈疽肿毒,溃疡疼痛,汤火灼伤,手足皲裂。《本经》:″主痈肿恶疮败疽,伤阴死肌,胃中邪气,贼风痱缓不收。″《日华子本草》:″止惊邪、血邪,痢疾,赤眼,症结,发背,瘰疬,肠风,痔瘿,刀箭疮扑损,温热疟疾,血痢,汤火疮,生肌止痛,风痹。″
苦参味苦;性寒。归肝;肾;大肠;小肠经;膀胱;心经;膀胱经。功效:清热燥湿:广泛应用与多重湿热病症,如湿热泻痢外用可以煎汤外洗,用于痔疮,妇女妇科。清热燥湿,杀虫,利尿。用于热痢,便血,黄疸尿闭,赤白带下,阴肿阴痒,湿疹,湿疮,皮肤瘙痒,疥癣麻风;外治滴虫性阴道炎。美容护肤作用:性寒,有清热燥湿,杀虫的功效,苦参浴能够清除下焦湿热,并且杀虫止痒,对皮肤瘙痒有很好的缓解作用,植物中草药能够平衡油脂分泌,疏通并收敛毛孔,清除皮肤内毒素杂质,丰富的本草营养,促进受损血管神经细胞的生长和修复,恢复皮下毛细血管细胞活力,肌肤重现紧致细滑,起到美容护肤的作用。《神农本草经》:主心腹结气,症瘕积聚,黄疸,溺有余沥,逐水,除痈肿,补中,明目止泪。《名医别录》:养肝胆气,安五脏,定志益精,利九窍,除伏热肠澼,止渴,醒酒,小便黄赤,疗恶疮下部疡,平胃气,令人嗜食。
白芷性味归经:辛,温。归肺、胃经。祛风散寒,通窍止痛,消肿排脓,燥湿止带。《日华子本草》:治目赤胬肉,及补胎漏滑落,破宿血,补新血,乳痈、发背、瘰疬、肠风、痔瘘,排脓,疮痍、疥癣,止痛生肌,去面皯疵瘢。
本发明外用栓剂的制作过程为:将艾叶1500g,血竭1500g、白芷1500g和白及1500g蒸馏汽化成结晶,粉碎备用;将其余原料地榆炭1500g,黄芩1500g,百花蛇舌草1500g,川芎1500g,金银花1500g,丹参1500g,炒槐角1500g,紫草1500g,荆芥炭1500g,败酱草1500g,黄柏1500g,大黄1500g,鸡血藤1500g,苦参1500g,晾晒好放入粉碎机打成粗颗粒,泡入乙醇中24小时以上,将浸泡好的其余原料放入乙醇中加热回流提取2次,每次1~2小时,将2次提取液合并静置,去上清液,合并提取液,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.36的浸膏,加热浓缩至膏状,静置备用,成为组分1。将上述乙醇提取过的药渣加10倍量水加热回流提取2次,每次1~2小时,将2次提取液合并静置,去上清液,合并提取液,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.36的浸膏,加热浓缩至膏状,静置备用,成为组分2。将上述组分1与组分2合并,减压回收乙醇后置入双效真空浓缩器中,浓缩至90℃时相对密度为1.05的浸膏,浓缩至每1ml含1g生药量,加上步骤a得到的结晶粉末,加入上述浓缩浸膏中,基质调和罐装定型,紫外线杀毒。
所述栓剂所用的基质选自:半合成脂肪酸甘油酯、泊洛沙姆、聚乙二醇、羊毛脂中的一种或多种;所述基质在温度50℃~60℃条件下加热融化,加入所述制备方法制得的药物膏体,水浴搅拌均匀,混合成粘稠的液体,灌注在塑料定型管内
本发明外用灌肠剂的制备过程:先将血竭1200g、艾叶1100g,白及1200g,白芷1200g,蒸馏法蒸馏汽化成结晶,粉碎成细粉备用;然后将地榆炭1200g,黄芩1300g,百花蛇舌草1300g,川芎1200g,金银花1100g,丹参1200g,炒槐角1200g,紫草1100g,荆芥炭1200g,败酱草1200g,黄柏1100g,大黄1100g,鸡血藤1200g,苦参1200g,加入5-10倍量水的浸泡1-2小时,加热提取2次,每次1-2小时,去上清液,合并提取液,80-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.36的浸膏,加热浓缩,30分钟~45分钟,提取活性成份,将浓缩液静置成药糊状,再合并加汽化的结晶,紫外线杀菌后装袋。
取其药液,自然沉淀后取上清液加温浓缩至200mL。患者取侧卧位,取药液50mL,加温至37℃左右用注射器抽取药液,缓缓注人肛内。保留2~4h,每晚1次,10d为1疗程。一般用药1~2个疗程。
本发明喷雾剂的制备方法:先将血竭1300g、艾叶1400g、白及1200g、白芷1400g,蒸馏法蒸馏汽化成结晶;然后将地榆炭1200g,黄芩1100g,百花蛇舌草1200g,川芎1200g,金银花1200g,丹参1100g,炒槐角1200g,紫草1200g,荆芥炭1100g,败酱草1200g,黄柏1100g,大黄1100g,鸡血藤1100g,苦参1100g,放入乙醇中加热回流提取2次,每次1~2小时,将2次提取液合并静置,去上清液,合并提取液,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.36的浸膏,加热浓缩至膏状,静置备用,成为组分1。将上述乙醇提取过的药渣加10倍量水加热回流提取2次,每次1~2小时,将2次提取液合并静置,去上清液,合并提取液,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.36的浸膏,加热浓缩至膏状,静置备用,成为组分2。将上述组分1与组分2合并,减压回收乙醇后置入双效真空浓缩器中,浓缩至90℃时相对密度为1.05的浸膏,浓缩至每1ml含1g生药量,然后加上述步骤得到的结晶粉末,搅拌均匀后装入医用喷雾器中。
本发明外用膏药剂的制备方法为:先将血竭1300g、艾叶1400g、白及1400g、白芷1400g,蒸馏法蒸馏汽化成结晶;然后将地榆炭1300g,黄芩1500g,百花蛇舌草1500g,川芎1500g,金银花1400g,丹参1500g,炒槐角1300g,紫草1100g,荆芥炭1500g,败酱草1500g,黄柏1300g,大黄1200g,鸡血藤1500g,苦参1300g,;加入5-10倍重量份的麻油中浸泡7-10天,加热提取有效成分,大火煮沸,麻油沸腾后火力减小,熬至药物外表呈深褐色,内部焦黄色,捞出药渣,将药油继续熬炼,并不断搅拌,炼至滴水成珠;将铅丹炒至朱红色,除去水分,过100-120目筛除去杂质;将铅丹缓慢加入炼好的药油中,不断搅拌,成黑色的稠膏,炼好的膏药稍冷后倾入冷水中,浸泡5-10天,每日换水一次,去火毒;成药后加粉碎的结晶粉末搅拌均匀,外用。
Claims (4)
1.一种具有清热解毒功效的肛乳头中药制剂,其特征在于,所述肛乳头中药制剂为外用制剂,所述中药外用制剂中各种原料药的重量份数包括:地榆炭10~20份,黄芩10~20份,百花蛇舌草10~20份,川芎10~20份,金银花10~20份,丹参10~20份,炒槐角10~20份,紫草10~20份,荆芥炭10~20份,败酱草10~20份,黄柏10~20份,大黄10~20份,鸡血藤10~20份,艾叶10~20份,血竭10~20份,白芷10~20份,白及10~20份,苦参10~20份。
2.根据权利要求1所述具有清热解毒功效的肛乳头中药制剂,其特征在于,所述中药外用制剂中各种原料药的重量份数包括:地榆炭10~15份,黄芩10~15份,百花蛇舌草10~15份,川芎10~15份,金银花10~15份,丹参10~15份,炒槐角10~15份,紫草10~15份,荆芥炭10~15份,败酱草10~20份,黄柏10~20份,大黄10~20份,鸡血藤10~20份,艾叶10~20份,血竭10~20份,白芷10~20份,白及10~20份,苦参10~20份。
3.根据权利要求1所述具有清热解毒功效的肛乳头中药制剂,其特征在于,所述中药外用制剂中各种原料药的重量份数包括:地榆炭10~20份,黄芩10~20份,百花蛇舌草10~20份,川芎10~20份,金银花10~20份,丹参10~20份,炒槐角10~20份,紫草10~20份,荆芥炭10~20份,败酱草10~15份,黄柏10~15份,大黄10~15份,鸡血藤10~15份,艾叶10~15份,血竭10~15份,白芷10~15份,白及10~15份,苦参10~15份。
4.根据权利要求1~3中任一项所述具有清热解毒功效的肛乳头中药制剂,其特征在于,所述中药制剂的药物剂型为:喷雾剂、软膏、酊剂、膏剂、贴剂、中药熏洗剂、洗剂、栓剂或灌肠剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510855758.8A CN105343541A (zh) | 2015-11-28 | 2015-11-28 | 一种具有清热解毒功效的肛乳头中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510855758.8A CN105343541A (zh) | 2015-11-28 | 2015-11-28 | 一种具有清热解毒功效的肛乳头中药制剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105343541A true CN105343541A (zh) | 2016-02-24 |
Family
ID=55319700
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510855758.8A Pending CN105343541A (zh) | 2015-11-28 | 2015-11-28 | 一种具有清热解毒功效的肛乳头中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105343541A (zh) |
-
2015
- 2015-11-28 CN CN201510855758.8A patent/CN105343541A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102091203B (zh) | 一种治疗难愈性创面的外用中药制剂及其制备方法 | |
CN102048894B (zh) | 一种治疗烧伤的中药组合物及其制备方法 | |
CN102847063B (zh) | 一种治疗气血两虚血瘀型糖尿病足的中药组合物及其制备方法 | |
CN102049008B (zh) | 一种治疗黄褐斑的中药组合物及其制备方法 | |
CN103169928B (zh) | 治疗痛经的外用中药组合物及其制备方法和应用 | |
CN103751709A (zh) | 一种治疗黄褐斑的中药组合物及其制备方法 | |
CN103520572A (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN103751663A (zh) | 一种治疗肛周湿疹的中药外用制剂及其制备方法 | |
CN103751633A (zh) | 一种治疗下肢静脉曲张的中药组合物及其制备方法 | |
CN103316146B (zh) | 一种麻醉用中药制剂 | |
CN102000164A (zh) | 一种治疗银屑病的中药组合物及其制备方法 | |
CN102772712B (zh) | 一种治疗热毒炽盛血瘀型糖尿病足的中药组合物 | |
CN102846824B (zh) | 一种治疗寒湿血瘀阻络型糖尿病足的中药组合物及其制备方法 | |
CN104771678A (zh) | 一种治疗血栓性静脉炎的药物及其制备方法 | |
CN104689279A (zh) | 一种用于子宫腺肌病的中药制剂及制备方法 | |
CN106038802A (zh) | 治疗妇女卵巢早衰的中药组合物制备方法及其组合物 | |
CN104758754A (zh) | 一种治疗肾气虚衰型前列腺增生的药物及制备方法 | |
CN105343541A (zh) | 一种具有清热解毒功效的肛乳头中药制剂 | |
CN104127737A (zh) | 用于防治痔疮术后并发症的药物组合物及其制备方法 | |
CN103690799A (zh) | 一种治疗脑梗塞的中药制剂 | |
CN104352788A (zh) | 一种治疗肛乳头炎的中药外用制剂及其制备方法 | |
CN106038981A (zh) | 一种治疗阴虚血热型足跟痛的中药组合物及其制备方法 | |
CN105726850A (zh) | 一种治疗烧烫伤、外伤出血的药物制剂及其制备方法 | |
CN105125714A (zh) | 一种治疗化疗性静脉炎的中药制剂及其制备方法 | |
CN105267895A (zh) | 用于治疗牛产后血瘀型胞衣不下的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160224 |